Who to call at Qualigen Therapeutics, and when
Fundz watches for the moments Qualigen Therapeutics starts buying, and tells you who to reach.
- An alert the day Qualigen Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Qualigen Therapeutics, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
LaunchQualigen Therapeutics Inc. is rebranding as AIxCrypto and launching the BesTrade DeAI Agent, aimed at optimizing trading transactions.
Oct 28, 2025
CarlsbadBiotechnologyHealth CareTherapeuticsProduct Description
Qualigen Therapeutics Inc. announced the launch of its BesTrade DeAI Agent as part of its new crypto asset business initiatives, targeting a public beta release by the end of November 2025.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Qualigen Therapeutics ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Product Launch Insights
What this usually meansMarket expansion signals
New product launches often coincide with market expansion initiatives
Qualigen Therapeutics shipped something new. Fundz reads product launches, trademark filings and hiring together.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.